Vivos (RDGL) Net Cash Flow Growth (5y) (2015 - 2025)
Vivos (RDGL) Net Cash Flow Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn |
| 10 | Vivos | 24.90 Mn | 23.34 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -21.13% |
| Sep 30, 2025 | -14.41% |
| Jun 30, 2025 | -34.97% |
| Mar 31, 2025 | 134.19% |
| Dec 31, 2024 | 55.86% |
| Sep 30, 2024 | -39.98% |
| Jun 30, 2024 | 66.05% |
| Mar 31, 2024 | -51.95% |
| Dec 31, 2023 | 58.78% |
| Jun 30, 2023 | -622.20% |
| Mar 31, 2023 | -104.05% |
| Dec 31, 2022 | -82.82% |
| Sep 30, 2022 | 4.02% |
| Jun 30, 2022 | -20.06% |
| Mar 31, 2022 | -146.89% |
| Dec 31, 2021 | 34.94% |
| Sep 30, 2021 | -15.48% |
| Jun 30, 2021 | -6.98% |
| Mar 31, 2021 | 87.77% |
| Dec 31, 2020 | 38.94% |